Company / R&D per Share
Disc Medicine, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.83
FY2025
5-year range
$3.10 / $32.17
FY2021-FY2025
Trend
+38.1%
vs FY2024
Sector context
#36 of 208
Health Care
What the data says
Disc Medicine, Inc.'s r&d per share of $4.83 is higher than 83% of companies in the Health Care sector (FY2025). Improved from $3.10 to $4.83 over the past 2 years.
Based on SEC 10-K filings.
4.83 in FY2025 with a 5-year CAGR of +21.0%. Top quartile in the Health Care sector.
Improved from $3.10 to $4.83 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -46.8%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 208This company $4.83 Sector average $12.19
▼
-60.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 38.1% year-over-year.
- Ranks #36 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.83 | +38.1% |
| FY2024 | $3.50 | +12.8% |
| FY2023 | $3.10 | -90.4% |
| FY2022 | $32.17 | +12.3% |
| FY2021 | $28.65 | +1437.5% |
| FY2020 | $1.86 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026